Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Superior Prima Sukses Tbk. (BLES) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Superior Prima Sukses Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Superior Prima Sukses Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp140 (market cap 1.25T, 591.3K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 4× Diagnos Laboratorium Utama Tbk.'s market cap, and Superior Prima Sukses Tbk. is more actively traded (591.3K versus 159.2K). Which is the better fit depends on your goals.

BLESDGNS
Market Cap
1.25T310.75B
Volume
591.3K159.2K
Lot
5.91K1.59K
Turnover
83.24M34.72M
Average Price
140.77218.06
Value
83.24M34.72M
Indicative Equilibrium Price
140220
Indicative Equilibrium Volume
4086

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BLES
View details
DGNS
View details

About Superior Prima Sukses Tbk.

PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.

Read more on BLES

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS